HBIO vs CSBR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 29, 2026

HBIO

51.0
AI Score
VS
HBIO Wins

CSBR

44.5
AI Score

Investment Advisor Scores

HBIO

51score
Recommendation
HOLD

CSBR

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HBIO CSBR Winner
Revenue 20.75M 45.59M CSBR
Net Income -3.42M -508,000 CSBR
Net Margin -16.5% -1.1% CSBR
Operating Income -1.17M -618,000 CSBR
ROE -34.1% -11.9% CSBR
ROA -4.4% -1.8% CSBR
Total Assets 77.94M 28.45M HBIO
Cash 7.10M 7.13M CSBR
Current Ratio 1.99 0.98 HBIO
Free Cash Flow -1.09M -2.80M HBIO

Relative Price Performance (Last 90 Days)

HBIO 1M: +0.8% · 3M: -4.4% CSBR 1M: -11.3% · 3M: -10.1%

Current Technical Phase

HBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $6.10

CSBR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 37

RSI (14): 36.7 · Price: $5.36

Fundamentals Snapshot

Metric HBIO CSBR
Market Cap
Forward P/E 13.9 53.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.6% 0.5%
Operating Margin 0.0% 0.0%
EPS -2.15 -0.18
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.